AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33084075 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyract XP
Number of subjects: 57
Study 33084075 — intervention group
Group type: EXPERIMENTAL
Intervention: Equia Forte
Number of subjects: 57
Study 33084075 — intervention group
Group type: EXPERIMENTAL
Intervention: ChemFil Rock
Number of subjects: 57
Study 35245626 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-supported detection (dentalXrai Pro 1.0.4)
Number of subjects: 23
Study 35245626 — intervention group
Group type: COMPARATOR
Intervention: Detection without AI
Number of subjects: 23
Study 35245626 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-supported detection
Number of subjects: 23
Study 33216969 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone foam dressings with standard prevention (n = 1087 pooled from experimental groups 1 and 2)
Number of subjects: 1633
Study 33216969 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (n = 546)
Number of subjects: 1633
Study 33216969 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone foam dressings with standard prevention (n = 1087)
Number of subjects: 1633
Study 32920689 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (patients with AAA)
Number of subjects: 220
Study 32920689 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (patients without AAA)
Number of subjects: 220
Study 36241121 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 μM Mn
Number of subjects: 4
Study 36241121 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 μM Mn
Number of subjects: 4
Study 36241121 — intervention group
Group type: COMPARATOR
Intervention: Control (2 μM Mn)
Number of subjects: 4
Study 36241121 — intervention group
Group type: EXPERIMENTAL
Intervention: L. multiflorum (exotic species)
Number of subjects: 4
Study 36241121 — intervention group
Group type: EXPERIMENTAL
Intervention: P. notatum (native species)
Number of subjects: 4
Study 32495305 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproductive healthcare services from obstetrics and gynecology
Number of subjects: 1500
Study 32495305 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproductive healthcare at health department
Number of subjects: 1500
Study 32495305 — intervention group
Group type: EXPERIMENTAL
Intervention: Most effective methods of contraception
Number of subjects: 1500
Study 32495305 — intervention group
Group type: EXPERIMENTAL
Intervention: General contraceptive use and insurance coverage
Number of subjects: 1500
Study 32311780 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipegfilgrastim (LIPEG) 6 mg
Number of subjects: 77
Study 32311780 — intervention group
Group type: COMPARATOR
Intervention: Pegfilgrastim (PEG) 6 mg
Number of subjects: 77
Study 35903379 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS) prediction based on multivariate Cox regression model.
Number of subjects: 44975
Study 35903379 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS) prediction.
Number of subjects: 44975
Study 33345452 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors (assumed risk reduction based on EMPA-REG OUTCOME and DECLARE-TIMI 58 trials)
Number of subjects: 23340
Study 33345452 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors (75% adoption)
Number of subjects: 23340
Study 32559278 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education lessons through SNAP‐Ed
Number of subjects: 0
Study 36057390 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-staged invitation procedure (pre-notification, invitation, and two reminders)
Number of subjects: 59041
Study 36057390 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-staged invitation procedure (invitation and two reminders)
Number of subjects: 59041
Study 36057390 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-staged invitation procedure (pre-notification, invitation, and one reminder)
Number of subjects: 59041
Study 36057390 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual procedure: invitation and one reminder)
Number of subjects: 59041
Study 36057390 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra reminder for males
Number of subjects: 59041
Study 36057390 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra reminder for females
Number of subjects: 59041
Study 36057390 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-staged invitation procedure for age group 50-59 years
Number of subjects: 59041
Study 33620016 — intervention group
Group type: EXPERIMENTAL
Intervention: rSIFN-co nebulization
Number of subjects: 94
Study 33620016 — intervention group
Group type: COMPARATOR
Intervention: Interferon-alpha nebulization
Number of subjects: 94
Study 32534376 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (30 mg elemental zinc)
Number of subjects: 60
Study 32534376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34978169 — intervention group
Group type: EXPERIMENTAL
Intervention: First semen sample after 2-7 days of abstinence
Number of subjects: 67
Study 34978169 — intervention group
Group type: EXPERIMENTAL
Intervention: Second semen sample collected 1-3 hours after the first
Number of subjects: 67
Study 34095908 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time monitoring of DNA hybridization on spherical particles functionalized with oligonucleotide capture probes in a microfluidic system.
Number of subjects: 0
Study 34095908 — intervention group
Group type: EXPERIMENTAL
Intervention: Bead bed hybridization with Streptococcus agalactiae cfb gene amplicons.
Number of subjects: 0
Study 34095908 — intervention group
Group type: COMPARATOR
Intervention: Conventional (passive) microfluidic microarray hybridization on glass slides.
Number of subjects: 0
Study 34095908 — intervention group
Group type: COMPARATOR
Intervention: Centrifugally-driven (active) microfluidic microarray hybridization on glass slides.
Number of subjects: 0
Study 35112890 — intervention group
Group type: EXPERIMENTAL
Intervention: ivabradine (5 mg BID, 1-week)
Number of subjects: 19
Study 35112890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 32734564 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) combined with rehabilitation training
Number of subjects: 74
Study 32734564 — intervention group
Group type: COMPARATOR
Intervention: Conventional drug therapy and rehabilitation training (Control)
Number of subjects: 74
Study 33269798 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinovac EV71 vaccine
Number of subjects: 600
Study 33269798 — intervention group
Group type: COMPARATOR
Intervention: Control EV71 vaccine
Number of subjects: 600
Study 33271095 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemogenovatucel-T (1 × 10^7 cells per injection), administered intradermally (one per month) for a minimum of four and up to 12 doses.
Number of subjects: 91
Study 33271095 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered intradermally (one per month) for a minimum of four and up to 12 doses.
Number of subjects: 91
Study 33271095 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemogenovatucel-T
Number of subjects: 91
Study 33271095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 33271095 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 91
Study 33713335 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-esteem group with treatment as usual (TAU)
Number of subjects: 50
Study 33713335 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 50
Study 33094848 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition support interventions during acute COVID-19
Number of subjects: 439
Study 33094848 — intervention group
Group type: EXPERIMENTAL
Intervention: Registered dietitian nutritionist counseling
Number of subjects: 439
Study 33094848 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition topics related to food insecurity and societal infrastructure
Number of subjects: 439
Study 33094848 — intervention group
Group type: EXPERIMENTAL
Intervention: Malnutrition management
Number of subjects: 439
Study 33094848 — intervention group
Group type: EXPERIMENTAL
Intervention: Research on transcultural factors
Number of subjects: 439
Study 33094848 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition research gaps in pediatrics
Number of subjects: 439
Study 33094848 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition research gaps in micronutrients and bariatric surgery
Number of subjects: 439
Study 33094848 — intervention group
Group type: EXPERIMENTAL
Intervention: Home enteral and parenteral nutrition support
Number of subjects: 439
Study 35939559 — intervention group
Group type: COMPARATOR
Intervention: ESO 20 mg plus AMX 750 mg, Qid for 14 days (Group A)
Number of subjects: 945
Study 35939559 — intervention group
Group type: EXPERIMENTAL
Intervention: ESO 40 mg Bid plus AMX 1 g Tid for 14 days (Group B)
Number of subjects: 945
Study 35939559 — intervention group
Group type: EXPERIMENTAL
Intervention: ESO 20 mg plus AMX 1 g, Tid for 14 days (Group C)
Number of subjects: 945
Study 34092255 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical high-linoleate sunflower seed oil (SSO) applied at 3 g/kg three times daily for 10 days
Number of subjects: 212
Study 34092255 — intervention group
Group type: COMPARATOR
Intervention: No emollient (control group)
Number of subjects: 212
Study 34092255 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical high-linoleate sunflower seed oil (SSO)
Number of subjects: 212
Study 32838554 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleeding (BARC 2, 3, or 5)
Number of subjects: 15968
Study 32838554 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial Infarction (MI)
Number of subjects: 15968
Study 32838554 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive bleeding
Number of subjects: 15968
Study 32838554 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive MI
Number of subjects: 15968
Study 32838554 — intervention group
Group type: EXPERIMENTAL
Intervention: Both bleeding and MI
Number of subjects: 15968
Study 32838554 — intervention group
Group type: EXPERIMENTAL
Intervention: De-escalation of antiplatelet therapy at the time of BARC 3 bleeding
Number of subjects: 15968
Study 32838554 — intervention group
Group type: COMPARATOR
Intervention: Overall mortality
Number of subjects: 15968
Study 33608479 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-positive MSM
Number of subjects: 355
Study 33608479 — intervention group
Group type: COMPARATOR
Intervention: HIV-negative MSM
Number of subjects: 355
Study 34663681 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-minute high-intensity interval exercise program (jumps, squats, various steps) implemented twice weekly over 10 weeks for 10 to 25 minutes per session
Number of subjects: 2101
Study 34663681 — intervention group
Group type: COMPARATOR
Intervention: Usual physical education class
Number of subjects: 2101
Study 33351532 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV seroconversion
Number of subjects: 605
Study 33351532 — intervention group
Group type: EXPERIMENTAL
Intervention: GC/CT positive cases
Number of subjects: 605
Study 33351532 — intervention group
Group type: COMPARATOR
Intervention: GC/CT negative controls
Number of subjects: 605
Study 32433428 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral carbohydrate (CHO) group
Number of subjects: 82
Study 32433428 — intervention group
Group type: COMPARATOR
Intervention: IV Dextrose group
Number of subjects: 82
Study 34036337 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive mobilization (30 minutes, 5 times/week for 4 weeks)
Number of subjects: 45
Study 34036337 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (Control group)
Number of subjects: 45
Study 33300809 — intervention group
Group type: EXPERIMENTAL
Intervention: High power (45 W)
Number of subjects: 100
Study 33300809 — intervention group
Group type: COMPARATOR
Intervention: Standard CLOSE protocol (35 W)
Number of subjects: 100
Study 32602792 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing in the last three days
Number of subjects: 960
Study 32602792 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing in the last three days
Number of subjects: 960
Study 32602792 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement in reading, counting, drawing, 'showing and naming', and 'chatting'
Number of subjects: 960
Study 34482350 — intervention group
Group type: EXPERIMENTAL
Intervention: F/TAF 200 mg/25 mg
Number of subjects: 79
Study 34482350 — intervention group
Group type: COMPARATOR
Intervention: F/TDF 200 mg/300 mg
Number of subjects: 79
Study 32089078 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session weekly yoga intervention
Number of subjects: 37
Study 32089078 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 37
Study 32089078 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 37
Study 32089078 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 37
Study 35319653 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscotrabeculotomy with anterior chamber irrigation
Number of subjects: 43
Study 35319653 — intervention group
Group type: COMPARATOR
Intervention: Ahmed glaucoma valve implantation
Number of subjects: 43
Study 33337732 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal injections of 50 units of BoNTA
Number of subjects: 30
Study 33337732 — intervention group
Group type: COMPARATOR
Intervention: Laser-assisted transcutaneous BoNTA delivery using fractional CO2 laser (25, 50, and 75 units)
Number of subjects: 30
Study 33287836 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment in PCOS patients (PCOS-GH)
Number of subjects: 93
Study 33287836 — intervention group
Group type: COMPARATOR
Intervention: Control group (PCOS-C)
Number of subjects: 93
Study 32618554 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory analysis of Na content in bread
Number of subjects: 3239
Study 32618554 — intervention group
Group type: COMPARATOR
Intervention: Nutrient labels of bread
Number of subjects: 3239
Study 32618554 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of salt content per roll
Number of subjects: 3239
Study 32618554 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of rolls
Number of subjects: 3239
Study 33075788 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 27
Study 33075788 — intervention group
Group type: COMPARATOR
Intervention: Diet based on NICE guidelines
Number of subjects: 27
Study 36263739 — intervention group
Group type: EXPERIMENTAL
Intervention: Osmotic-release oral system methylphenidate (OROS-methylphenidate)
Number of subjects: 0
Study 36263739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34407810 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-step LSPPDM pedagogy (Learn, See, Practice, Prove, Do, Maintain)
Number of subjects: 60
Study 34407810 — intervention group
Group type: COMPARATOR
Intervention: Traditional 2-step method (Learn, Practice)
Number of subjects: 60
Study 35948418 — intervention group
Group type: EXPERIMENTAL
Intervention: OPEP therapy using Acapella device for 3 months
Number of subjects: 122
Study 35948418 — intervention group
Group type: COMPARATOR
Intervention: Usual care (including active cycle of breathing technique)
Number of subjects: 122
Study 34391315 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates training
Number of subjects: 30
Study 34391315 — intervention group
Group type: EXPERIMENTAL
Intervention: Suspension training
Number of subjects: 30
Study 35623878 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous 2 g of vitamin C in normal saline
Number of subjects: 80
Study 35623878 — intervention group
Group type: COMPARATOR
Intervention: Normal saline therapy (control)
Number of subjects: 80
Study 34503460 — intervention group
Group type: EXPERIMENTAL
Intervention: Skull remodeling surgery, Tumor Treating Fields therapy (TTFields), and best practice oncology
Number of subjects: 84
Study 34503460 — intervention group
Group type: COMPARATOR
Intervention: Tumor Treating Fields therapy (TTFields) and best physicians choice oncological treatment (control arm)
Number of subjects: 84
Study 32618829 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) 300 mg daily for 6 months
Number of subjects: 64
Study 32618829 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 34259302 — intervention group
Group type: COMPARATOR
Intervention: 30% RD43 rice noodles
Number of subjects: 0
Study 34259302 — intervention group
Group type: COMPARATOR
Intervention: 10-40% RD43 rice flour
Number of subjects: 0
Study 33111883 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional restorative Glass Ionomer Cement (Fuji Bulk)
Number of subjects: 30
Study 33111883 — intervention group
Group type: COMPARATOR
Intervention: Posterior resin composite (G-ænial Posterior)
Number of subjects: 30
Study 35871083 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Neu2000K
Number of subjects: 150
Study 35871083 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose Neu2000K
Number of subjects: 150
Study 35871083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 33483990 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 39
Study 33483990 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 39
Study 32682962 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter tricuspid valve intervention (TTVI)
Number of subjects: 124
Study 32682962 — intervention group
Group type: COMPARATOR
Intervention: Guideline directed medical therapy (GDMT)
Number of subjects: 124
Study 36210809 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalazine (4.0 g/d, once a day for 3 months)
Number of subjects: 82
Study 32589129 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading Dose (LD) 600 mg
Number of subjects: 402
Study 32589129 — intervention group
Group type: COMPARATOR
Intervention: Reloading (RL) 300 mg
Number of subjects: 402
Study 32589129 — intervention group
Group type: COMPARATOR
Intervention: Maintenance Dose (MD) 75 mg/day
Number of subjects: 402
Study 36093863 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS + cognitive training
Number of subjects: 62
Study 36093863 — intervention group
Group type: COMPARATOR
Intervention: tDCS alone
Number of subjects: 62
Study 36093863 — intervention group
Group type: COMPARATOR
Intervention: Cognitive training alone
Number of subjects: 62
Study 33945920 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (PC) group
Number of subjects: 0
Study 33945920 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) group
Number of subjects: 0
Study 32412119 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation (CBA) for pulmonary vein isolation (PVI) and left atrial substrate modification
Number of subjects: 26
Study 34481420 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBM) combined with standard skincare (2x/week) during the complete radiotherapy course
Number of subjects: 71
Study 34481420 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment combined with standard skincare (2x/week)
Number of subjects: 71
Study 34815179 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum metabolic profiling on day 1
Number of subjects: 202
Study 34815179 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum metabolic profiling on day 8
Number of subjects: 202
Study 34815179 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum levels of 1-arachidonoyl-lysoPC and 1-eicosatetraenoyl-lysoPC
Number of subjects: 202
Study 34815179 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum levels of amino acids and amino acid metabolites
Number of subjects: 202
Study 34578999 — intervention group
Group type: EXPERIMENTAL
Intervention: Macronutrient-based diet
Number of subjects: 42
Study 34578999 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (16:8)
Number of subjects: 42
Study 34972618 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep supra‐temporalis muscle subfascial approach (DSFA)
Number of subjects: 30
Study 34972618 — intervention group
Group type: COMPARATOR
Intervention: Traditional fascial approach (TFA)
Number of subjects: 30
Study 34972618 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (DSFA and TFA)
Number of subjects: 30
Study 34534926 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-subject GM networks analysis
Number of subjects: 51
Study 35367850 — intervention group
Group type: EXPERIMENTAL
Intervention: Textured insoles
Number of subjects: 30
Study 35367850 — intervention group
Group type: COMPARATOR
Intervention: Placebo insoles
Number of subjects: 30
Study 35367850 — intervention group
Group type: COMPARATOR
Intervention: Smooth (control) insoles
Number of subjects: 30
Study 32594300 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplantation (HSCT)
Number of subjects: 60
Study 34184795 — intervention group
Group type: EXPERIMENTAL
Intervention: On-line self-help intervention consisting of 10 modules based on cognitive-behavioral therapy and motivational interviewing.
Number of subjects: 589
Study 34184795 — intervention group
Group type: COMPARATOR
Intervention: Active control group received access to a website with a self-test including personalized normative feedback and information for standard alcohol treatment.
Number of subjects: 589
Study 34263533 — intervention group
Group type: EXPERIMENTAL
Intervention: Curriculum-based intervention founded on the elaboration likelihood model (ELM)
Number of subjects: 101
Study 34263533 — intervention group
Group type: COMPARATOR
Intervention: Education-based control intervention
Number of subjects: 101
Study 32168090 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation sessions
Number of subjects: 49
Study 35305810 — intervention group
Group type: EXPERIMENTAL
Intervention: UG (ultrasound group)
Number of subjects: 79
Study 35305810 — intervention group
Group type: COMPARATOR
Intervention: CG (control group)
Number of subjects: 79
Study 34978774 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment in patients with SCH
Number of subjects: 54
Study 34978774 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 54
Study 34978774 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical hypothyroidism (SCH)
Number of subjects: 54
Study 36062550 — intervention group
Group type: COMPARATOR
Intervention: Standard-care intervention (testing and phone feedback)
Number of subjects: 119